美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
42292-017-20	42292-017	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide	spironolactone and hydrochlorothiazide	TABLET	ORAL	20170512	N/A	ANDA	ANDA086513	Mylan Institutional Inc.	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25 mg/1; 25 mg/1	100 BLISTER PACK in 1 CARTON (42292-017-20) / 1 TABLET in 1 BLISTER PACK (42292-017-01)
0378-0403-01	0378-0403	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide	spironolactone and hydrochlorothiazide	TABLET	ORAL	19790803	N/A	ANDA	ANDA086513	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25 mg/1; 25 mg/1	100 TABLET in 1 BOTTLE, PLASTIC (0378-0403-01)
0378-0403-05	0378-0403	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide	spironolactone and hydrochlorothiazide	TABLET	ORAL	19790803	N/A	ANDA	ANDA086513	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25 mg/1; 25 mg/1	500 TABLET in 1 BOTTLE, PLASTIC (0378-0403-05)